PTPN11 and neoplasm: Overall, these results show that SHP2 silencing reduced the levels of several vascular regulators expressed in B16F10 cells, potentially driving reduced tumor vascularity, vessel remodeling, formation of tumor islands, and other changes in SHP2-silenced tumors.